Impact of heart failure on the behavior of human neonatal stem cells in vitro

dc.contributor.author

Klose, Kristin

dc.contributor.author

Roy, Rajika

dc.contributor.author

Brodarac, Andreja

dc.contributor.author

Kurtz, Andreas

dc.contributor.author

Ode, Andrea

dc.contributor.author

Kang, Kyung-Sun

dc.contributor.author

Bieback, Karen

dc.contributor.author

Choi, Yeong-Hoon

dc.contributor.author

Stamm, Christof

dc.date.accessioned

2023-09-01T17:04:58Z

dc.date.available

2023-09-01T17:04:58Z

dc.date.issued

2013-12

dc.date.updated

2023-09-01T17:04:58Z

dc.description.abstract

jats:titleAbstract</jats:title> jats:sec jats:titleBackground</jats:title> jats:pClinical cardiac cell therapy using autologous somatic stem cells is restricted by age and disease-associated impairment of stem cell function. Juvenile cells possibly represent a more potent alternative, but the impact of patient-related variables on such cell products is unknown. We therefore evaluated the behavior of neonatal cord blood mesenchymal stem cells (CB-MSC) in the presence of serum from patients with advanced heart failure (HF).</jats:p> </jats:sec> jats:sec jats:titleMethods</jats:title> jats:pHuman serum was obtained from patients with severe HF (n = 21) and from healthy volunteers (n = 12). To confirm the systemic quality of HF in the sera, TNF-α and IL-6 were quantified. CB-MSC from healthy neonates were cultivated for up to 14 days in medium supplemented with 10% protein-normalized human HF or control serum or fetal calf serum (FCS).</jats:p> </jats:sec> jats:sec jats:titleResults</jats:title> jats:pAll HF sera contained increased cytokine concentrations (IL-6, TNF-α). When exposed to HF serum, CB-MSC maintained basic MSC properties as confirmed by immunophenotyping and differentiation assays, but clonogenic cells were reduced in number and gave rise to substantially smaller colonies in the CFU-F assay. Cell cycle analysis pointed towards G1 arrest. CB-MSC metabolic activity and proliferation were significantly impaired for up to 3 days as measured by MTS turnover, BrdU incorporation and DAPI + nuclei counting. On day 5, however, CB-MSC growth kinetics approached control serum levels, though protein expression of cell cycle inhibitors (p21, p27), and apoptosis marker Caspase 3 remained elevated. Signal transduction included the stress and cytokine-induced JNK and ERK1/2 MAP kinase pathways.</jats:p> </jats:sec> jats:sec jats:titleConclusions</jats:title> jats:pHeart failure temporarily inhibits clonality and proliferation of “healthy” juvenile MSC jats:italicin vitro</jats:italic>. Further studies should address the jats:italicin vivo</jats:italic> and clinical relevance of this finding.</jats:p> </jats:sec>

dc.identifier.issn

1479-5876

dc.identifier.uri

https://hdl.handle.net/10161/28947

dc.language

en

dc.publisher

Springer Science and Business Media LLC

dc.relation.ispartof

Journal of Translational Medicine

dc.relation.isversionof

10.1186/1479-5876-11-236

dc.title

Impact of heart failure on the behavior of human neonatal stem cells in vitro

dc.type

Journal article

duke.contributor.orcid

Roy, Rajika|0000-0001-9394-3224

pubs.issue

1

pubs.organisational-group

Duke

pubs.organisational-group

School of Medicine

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Surgery

pubs.organisational-group

Surgery, Cardiovascular and Thoracic Surgery

pubs.publication-status

Published

pubs.volume

11

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Roy neonatal cells J Trans med.pdf
Size:
1.91 MB
Format:
Adobe Portable Document Format
Description:
Published version